I get asked about therapeutic laser almost every week, usually in some version of the same question: “We just bought a Class IV unit. Is that enough power?” The question is understandable, but power alone is not the whole answer. Wattage tells me how quickly a device can deliver energy. It does not, by itself, tell me whether the treatment area, wavelength, dose, and technique are appropriate for the tissue I am trying to reach.
That distinction matters because photobiomodulation is easy to oversimplify. A device can be powerful, expensive, and still poorly applied. A treatment can also look impressive on paper while lacking enough detail to be reproduced consistently from one visit to the next. When I think about PBM dosing, I want the parameters to be specific enough that another clinician could understand what was intended and why.
What Photobiomodulation Actually Does at the Cellular Level
Photobiomodulation describes the interaction of light in the red to near-infrared range with biological tissue in a way that is intended to influence cellular behavior without using heat as the primary mechanism. The proposed mechanisms most commonly discussed in the literature involve mitochondrial photoacceptors, especially cytochrome c oxidase, together with downstream effects on cellular signaling.
Clinically, the reason this matters is practical rather than theoretical. PBM is used in companion animal medicine because it may help support pain modulation, tissue healing, and rehabilitation goals in selected patients. Those effects appear to be dose-dependent, which is one reason dosing parameters and treatment documentation matter so much.
I try not to overstate the mechanism. The basic science is promising and the broader PBM literature is extensive, but that does not mean every device setting, every protocol, or every diagnosis is equally supported in dogs. What it does mean is that laser therapy should be dosed thoughtfully rather than treated like a generic “three minutes on the joint” modality.
Why Joules Per Square Centimeter Is an Important Dosing Parameter
A joule is a unit of energy. One joule equals one watt delivered for one second. Joules per square centimeter, or J/cm2, describes fluence, the amount of energy delivered over a defined surface area. That makes it a useful dosing parameter because it connects the treatment to the size of the region being treated rather than to time alone.
In practical terms, that is why a preset duration can be misleading. Sixty seconds on a tiny treatment zone is not the same thing as sixty seconds over a large periarticular region, and the tissue target may not be at the same depth in either patient. Fluence helps make that difference visible.
I still do not treat fluence as the only number that matters. It has to be interpreted together with wavelength, power, contact technique, and the characteristics of the patient. But if a record says only “laser, 3 minutes,” without power, area, or total joules, it is very difficult to know what dose was actually intended.
That is why I prefer laser documentation that includes at least the treatment area, the device settings, and the total energy delivered. Fluence is one of the best ways to turn a vague treatment description into something more clinically meaningful.
Depth of Penetration and Why Wavelength Matters
Wavelength matters because tissue does not interact with all light the same way. Red and near-infrared wavelengths are used in PBM because they fall within a range that is more useful for biological penetration than many other parts of the spectrum. In general terms, near-infrared wavelengths are often chosen when clinicians are trying to reach deeper targets than they could with more superficial red wavelengths.
That does not mean a specific wavelength guarantees a specific tissue depth in every dog. Penetration is influenced by multiple variables, including tissue composition, hydration, pigmentation, coat density, body condition, and whether the clinician is making direct skin contact or trying to treat through a heavy coat.
In canine patients, coat and pigmentation are not minor details. Dark pigmentation can increase surface absorption, and dense or poorly managed coats can reduce consistent delivery to the skin. That is one reason I part the coat when needed and focus on consistent contact technique instead of assuming the device will overcome every barrier automatically.
When the tissue target is deeper, I think less in terms of “what is the strongest laser?” and more in terms of “what wavelength, area, and technique make sense for the structure I am actually trying to influence?” That is a more clinically useful question.
Treatment Time Calculations and the Math We Actually Use
Treatment time is where marketing language and clinical reality often diverge. A short treatment may be appropriate for a small, superficial zone, but not every large-breed joint or periarticular region can be treated meaningfully with the same preset time.
The basic framework is straightforward:
- Total joules needed = Target fluence (J/cm2) x Treatment area (cm2)
- Treatment time (seconds) = Total joules needed / Output power (watts)
That formula is useful, but it is still only the starting point. If I am scanning the handpiece continuously, moving too quickly, losing contact, or treating an irregular area, the actual distribution of energy may not match the calculation perfectly. That is why technique matters as much as arithmetic.
For that reason, I use treatment time as part of a dosing plan, not as a shortcut. The math helps me define what I am aiming for. Consistent application is what gives that math a chance to mean something clinically.
The Canine Evidence Base for PBM
I want to be honest about where the canine evidence stands. The veterinary PBM literature is promising, but it is not uniform. Some canine studies, including work in osteoarthritis, report improvements in pain or lameness outcomes. At the same time, the literature remains heterogeneous, with variation in device type, wavelength, dosing description, patient selection, and outcome measures.
That heterogeneity is important because it explains why the literature can feel mixed. A study that uses one wavelength, one device class, one treatment schedule, and one disease population is not automatically comparable to another study using a different set of parameters. That is a research challenge, not necessarily proof that the modality is ineffective.
One of the most common methodological problems in the PBM literature is incomplete dosing description. If fluence, total energy, area treated, and application technique are not clearly reported, it becomes difficult to interpret whether a protocol truly tested the modality well or simply applied it inconsistently.
So when I discuss PBM with owners or colleagues, I try to strike the right balance. There is enough literature to justify thoughtful clinical use in selected cases. There is not enough consistency to support careless overconfidence or one-size-fits-all dosing claims.
How I Apply Laser Dosing in Practice
I use therapeutic laser as one part of a broader rehabilitation plan, not as a standalone solution. My protocol development starts with the target tissue. I want to know whether I am treating a superficial incision, periarticular soft tissue, a broader pain region, or a deeper musculoskeletal structure.
From there, I think about the treatment area, the likely depth of the target, the patient's coat and pigmentation, and whether direct contact is feasible. Superficial targets and deeper periarticular targets are not planned the same way, and I do not assume that a preset developed for one patient will automatically fit another.
I also document the settings I actually used. If a treatment works, I want to know what was done well enough to repeat it. If it does not appear to help, I want enough information to assess whether the problem was technique, dose, target selection, or simply that PBM was not the right emphasis for that stage of care.
Response matters more than theory alone. If I am using PBM in a rehabilitation case, I still want the patient's progress judged by gait, pain behavior, function, tolerance, and the overall treatment plan rather than by the fact that laser was applied.
Dosing Errors I See Clinicians Make
The first common error is relying on presets without understanding what they deliver. Presets can be useful starting points, but they are not a substitute for knowing the intended area, the total joules, and the clinical target. A large, heavily coated dog is not the same optical problem as a small, lightly coated dog.
The second is treating time as if it were dose. A three-minute treatment is not automatically better than a one-minute treatment, and a one-minute treatment is not automatically inadequate. Without power, area, and technique, time alone tells me very little.
The third is poor coat management and inconsistent contact. If the coat is thick, wet, or poorly parted, the treatment may be less consistent than the settings imply. Direct skin contact, when appropriate, is often one of the simplest ways to make dosing more reliable.
The fourth is incomplete documentation. If the record says only “laser done,” there is no reproducible protocol. At a minimum, I want the device parameters, total joules, region treated, and a note about technique.
The fifth is assuming that more power is automatically better. Higher-power devices can shorten treatment time, but they also increase the importance of application technique and thermal awareness. Speed can be useful. It is not the same thing as good dosing.
Therapeutic laser can be a valuable modality in canine rehabilitation, but it works best when the treatment is planned and documented with the same care given to any other therapeutic intervention. Watts matter, but they are only one part of the picture.